Recombinant multi-species SULT2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SULT2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. This gene sulfates dehydroepiandrosterone but not 4-nitrophenol, a typical substrate for the phenol and estrogen sulfotransferase subfamilies. Two alternatively spliced variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ARCI14,Alcohol sulfotransferase,HSST2,Hydroxysteroid sulfotransferase 2,ST2B1,SULT2B,SULT2B1,Sulfotransferase 2B1,Sulfotransferase family 2B member 1,Sulfotransferase family cytosolic 2B member 1 (ST2B1),Sult2b1

Target products collectionGo to SULT2B1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11593-Ag-1/ GM-Tg-hg-IP11593-Ag-2 Human SULT2B1 protein Human
GM-Tg-rg-IP11593-Ag-1/ GM-Tg-rg-IP11593-Ag-2 Rat SULT2B1 protein Rat
GM-Tg-mg-IP11593-Ag-1/ GM-Tg-mg-IP11593-Ag-2 Mouse SULT2B1 protein Mouse
GM-Tg-cynog-IP11593-Ag-1/ GM-Tg-cynog-IP11593-Ag-2 Cynomolgus/Rhesus macaque SULT2B1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11593-Ag-1/ GM-Tg-felg-IP11593-Ag-2 Feline SULT2B1 protein Feline
GM-Tg-cang-IP11593-Ag-1/ GM-Tg-cang-IP11593-Ag-2 Canine SULT2B1 protein Canine
GM-Tg-bovg-IP11593-Ag-1/ GM-Tg-bovg-IP11593-Ag-2 Bovine SULT2B1 protein Bovine
GM-Tg-equg-IP11593-Ag-1/ GM-Tg-equg-IP11593-Ag-2 Equine SULT2B1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11593-Ag-1/ GM-Tg-hg-IP11593-Ag-2; GM-Tg-rg-IP11593-Ag-1/ GM-Tg-rg-IP11593-Ag-2;
GM-Tg-mg-IP11593-Ag-1/ GM-Tg-mg-IP11593-Ag-2; GM-Tg-cynog-IP11593-Ag-1/ GM-Tg-cynog-IP11593-Ag-2;
GM-Tg-felg-IP11593-Ag-1/ GM-Tg-felg-IP11593-Ag-2; GM-Tg-cang-IP11593-Ag-1/ GM-Tg-cang-IP11593-Ag-2;
GM-Tg-bovg-IP11593-Ag-1/ GM-Tg-bovg-IP11593-Ag-2; GM-Tg-equg-IP11593-Ag-1/ GM-Tg-equg-IP11593-Ag-2
Products Name SULT2B1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SULT2B1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SULT2B1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.